Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Becton Dickinson and Co (BDX) Price & Performance

Abeona Therapeutics IncTrade
Becton Dickinson and CoTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Becton Dickinson and Co — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 117.3× Abeona Therapeutics Inc's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOBDX
Market Cap
$421.19M$49.41B
Sector
HealthHealth
52-Week High
$7.45$185.39
52-Week Low
$4.17$138.62
Enterprise Value
$276.10M$65.51B
Dividend Yield
2.32%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX